Your Cart Is Empty!
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2014 annual average exchange rates.
- The Scandinavian pharmaceuticals market had total revenues of $12.8bn in 2014, representing a compound annual growth rate (CAGR) of 1.9% between 2010 and 2014.
- Sweden is the largest of the four markets but trends have been noticed that manufacturing appears to be shifting slightly in favour of Denmark in the region.
- The performance of the market is forecast to accelerate, with an anticipated CAGR of 2.5% for the five-year period 2014 - 2019, which is expected to drive the market to a value of $14.5bn by the end of 2019.
Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Scandinavia
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Scandinavia
Leading company profiles reveal details of key pharmaceuticals market players global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the Scandinavia pharmaceuticals market with five year forecasts
Macroeconomic indicators provide insight into general trends within the Scandinavia economy
Reasons To Buy
What was the size of the Scandinavia pharmaceuticals market by value in 2014?
What will be the size of the Scandinavia pharmaceuticals market in 2019?
What factors are affecting the strength of competition in the Scandinavia pharmaceuticals market?
How has the market performed over the last five years?
Who are the top competitiors in Scandinavias pharmaceuticals market?
Table of Contents
Executive Summary 2
Market value 2
Market value forecast 2
Geography segmentation 2
Market share 2
Market rivalry 2
Market Overview 6
Market definition 6
Market analysis 6
Market Data 7
Market value 7
Market Segmentation 8
Geography segmentation 8
Market share 9
Market Outlook 10
Market value forecast 10
Five Forces Analysis 11
Buyer power 12
Supplier power 14
New entrants 15
Threat of substitutes 16
Degree of rivalry 17
Leading Companies 19
Novartis AG 19
Pfizer Inc. 23
Sanofi SA 27
Industry associations 31
Related MarketLine research 31
About MarketLine 32
List of Tables
Table 1: Scandinavia pharmaceuticals market value: $ billion, 2010-14
Table 2: Scandinavia pharmaceuticals market geography segmentation: $ billion, 2014
Table 3: Scandinavia pharmaceuticals market share: % share, by value, 2014
Table 4: Scandinavia pharmaceuticals market value forecast: $ billion, 2014-19
Table 5: Novartis AG: key facts
Table 6: Novartis AG: key financials ($)
Table 7: Novartis AG: key financial ratios
Table 8: Pfizer Inc.: key facts
Table 9: Pfizer Inc.: key financials ($)
Table 10: Pfizer Inc.: key financial ratios
Table 11: Sanofi SA: key facts
Table 12: Sanofi SA: key financials ($)
Table 13: Sanofi SA: key financials (Euro)
Table 14: Sanofi SA: key financial ratios
List of Figures
Figure 1: Scandinavia pharmaceuticals market value: $ billion, 2010-14
Figure 2: Scandinavia pharmaceuticals market geography segmentation: % share, by value, 2014
Figure 3: Scandinavia pharmaceuticals market share: % share, by value, 2014
Figure 4: Scandinavia pharmaceuticals market value forecast: $ billion, 2014-19
Figure 5: Forces driving competition in the pharmaceuticals market in Scandinavia, 2014
Figure 6: Drivers of buyer power in the pharmaceuticals market in Scandinavia, 2014
Figure 7: Drivers of supplier power in the pharmaceuticals market in Scandinavia, 2014
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Scandinavia, 2014
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Scandinavia, 2014
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Scandinavia, 2014
Figure 11: Novartis AG: revenues and profitability
Figure 12: Novartis AG: assets and liabilities
Figure 13: Pfizer Inc.: revenues and profitability
Figure 14: Pfizer Inc.: assets and liabilities
Figure 15: Sanofi SA: revenues and profitability
Figure 16: Sanofi SA: assets and liabilities
Following are different modes of Licenses.
This license allows only one person to use the report. This person can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people. Unless you purchase a Site License or a Global Site License, a Single User License must be purchased for every single person that wishes to use the report within the same enterprise.
This license allows unlimited users to use the report within one company location, e.g. a regional office. These users can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people.
A Global Site License (or Enterprise wide Site License or Global License) is a license granted to original purchaser, who can share a report with other employees and authorized Users of the same organization.
The delivery of reports is depends on format & mode of license of report(s). Following are different kinds of formats of report(s) and their delivery options :
Report will be sent to your username email address in PDF, Excel, PowerPoint or any other electronic / softcopy format by publisher.
Delivery Time: 12 to 48 hours [depending on time difference or occurrences of national holidays]
Report will be sent through mail / courier delivery to your shipping address by publisher.
Delivery Time: Less than, few weeks [depending on time difference or occurrences of national holidays]
2. How can I make payment for publications I purchase?
You could be able to make the payment, in following ways:
b. Transfer of fund to our bank account via Bank transfer or Wire transfer
c. Payment via DD or Cheque
3. Is it safe to use my credit card on MarketinfoResearch?
Your personal information and online tranaction on Marketinfo Research is secure, private, and tamper-proof. All credit card payments are processed through secure and trusted payment gateways.